MedPath

Discussing COVID-19 Vaccines in Private Facebook Groups

Not Applicable
Completed
Conditions
COVID-19
Interventions
Behavioral: COVID-19 vaccine information
Behavioral: Gist messages on COVID-19 vaccination
Registration Number
NCT05422898
Lead Sponsor
George Washington University
Brief Summary

As the COVID-19 pandemic persists, a sizable proportion of the U.S. population remains unvaccinated and at high risk of death and serious illness from COVID-19. Vaccine hesitancy, fueled by the proliferation of vaccine misinformation on social media, is one factor contributing to lack of vaccination. Current attempts to overcome vaccine misinformation focus on correcting or debunking falsehoods. Although debunking strategies are important components to any public health campaign, communications must also address rationales for vaccine hesitancy that vary among individuals and communities, and directly address the gist of their concerns in an empathetic, non-judgmental manner. We will conduct a randomized controlled trial to test the effectiveness of empathic, relationship-building interactions relative to standard provision of information on social media to address COVID-19 vaccine hesitancy.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
508
Inclusion Criteria
  • reside in the U.S.
  • unvaccinated from COVID-19
  • Use Facebook regularly (at least 1/day)
Exclusion Criteria
  • age <18 years
  • do not reside in the U.S.
  • vaccinated from COVID-19
  • do not use Facebook regularly (at least 1/day)

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
InformationCOVID-19 vaccine informationLink to Facebook COVID-19 Information Center
GistGist messages on COVID-19 vaccinationGist-based messages on COVID-19 vaccination and moderated group discussions in a private Facebook group
Primary Outcome Measures
NameTimeMethod
Engagement and satisfaction with the program4 weeks

Engagement includes participation in the Facebook group; satisfaction=self-rated overall satisfaction with the program (7-point scale)

Secondary Outcome Measures
NameTimeMethod
Change in COVID-19 vaccination intention4 weeks

Self-reported intention to get the COVID-19 vaccine (7-point scale)

Change in COVID-19 vaccine confidence4 weeks

Self-reported confidence in the COVID-19 vaccine (5-point scale)

Change in general vaccine confidence4 weeks

Self-reported confidence in vaccines (7-point scale)

Change in intention to encourage others to get the COVID-19 vaccine4 weeks

Self-reported intention to encourage others to get the COVID-19 vaccine (7-point scale)

Proportion of participants getting the COVID-19 vaccine4 weeks

self-reported vaccination status

Change in vaccine hesitancy4 weeks

Self-reported vaccine hesitancy (7-point scale

Trial Locations

Locations (1)

George Washington University

🇺🇸

Washington, District of Columbia, United States

© Copyright 2025. All Rights Reserved by MedPath